Good news | Huibang Biotech won the China IVD Investment Value Award​

Date：

2023-05-27

On May 26th, the "Bright. Test" 6th Youth Entrepreneur Forum for In Vitro Diagnostic Reagents held at the Medical Testing Summit of the National Health Industry Enterprise Management Association was grandly held in the Greenland Primus Hotel Center of Nanchang International Expo City. Anhui Huibang Bioengineering Co., Ltd. stands out with original medical innovation ideas and subversive technologies. The market prospect is unlimited, and it has formed the prototype of a unicorn in the subdivision field. Value and Most Investment Value Award.

This conference brought together entrepreneurs, industry leaders, industry experts, senior investment partners and other industry leaders from well-known domestic in vitro diagnostic listed companies. From the four aspects of new track, new pursuit, new mission, and new vision, after layers of screening and rematch , 5 companies entered the final competition.

This selection has a wide coverage, high specifications, great influence, and strong professionalism. It is the most influential and credible event in the field of in vitro diagnostics in my country. Huibang Biology made a comprehensive and detailed report on the industrial chain, clinical needs, intellectual property rights, and diagnosis and treatment guidelines, and was highly recognized by well-known entrepreneurs and industry experts in the same industry. Huibang Biotechnology won the first place in this road show! At the same time, it has won the favor and recognition of industry medical experts and the capital market.

After the meeting, Wang Zhongliang, chairman of Huibang Biotechnology, said that behind the honor is a heavy responsibility. We will be more determined to take the road of original innovation, comprehensively deepen and improve product quality and refined management system, and provide customers with better products. products and services.

Huibang Biology has light in its heart and a path under its feet. Now that the dream has been built and set sail, we would like to thank leaders at all levels, experts, and capital parties for their care and support along the way. In the near future, all expectations and investments in Huibang Biotech will be fully realized.

 

Related News

2024-01-22

Serving the big health industry, leapfrogging development of industry, academia and research - Anhui Huibang Biotech bloomed at the Anhui Traditional Chinese Medicine Academic Annual Conference

2023-08-07

Urine and nephropathy and defense -Dialogue column of the Diabetes Branch of the Chinese Medical Association

On August 4, 2023, the Chinese Medical Association Diabetes Branch 2023 Education Management Academic Conference was grandly held at Fengda International Hotel, Hefei City, Anhui Province.

2023-06-29

Good news! Huibang Biotechnology won the second prize of Science and Technology Progress Award of the Ministry of Education!

Recently, the Ministry of Education issued a certificate for the Outstanding Achievement Award (Science and Technology) of Scientific Research in Institutions of Higher Learning. Anhui Huibang Bioengineering Co., Ltd. jointly with the Chinese Academy of Sciences and Capital Medical University declared the project: "Research and Application of Molecular Targets for Diabetes" won the second prize of Science and Technology Progress Award of the Ministry of Education.

2023-06-12

Huibang Biotech actively implements the Hangzhou Declaration and contributes to building a healthy China

On June 11, 2023, the first China Health Promotion Conference was successfully held in Hangzhou. The conference was high-level and large-scale, and many guests from the government, medical and health circles, sports circles, education circles, science and technology circles, mass media, NGO organizations and business circles attended.

2023-06-01

Good news! Huibang Biotechnology won the "Star of Creation" Cup Innovative Product Gold Award

Wisdom medicine is upright and innovative | "Star of Creation" The 8th China Experimental Medicine Conference was grandly opened on May 27 at the Primus Hotel Conference Center in Nanchang! Huibang Bio's innovative product insulin-like growth factor binding protein-1/fetal fiber Connexin (IGFBP-1/fFN) detection kit won the 2022 "Innovation Star" Cup China Excellent Innovative Product Gold Award for In Vitro Diagnostics.